Louisiana is funding psilocybin, ibogaine and MDMA trials with opioid settlement money. If a drug comes out of it, the state takes 20% of profits. A state health department holding equity in a Schedule I medicine is new. bit.ly/4w8ZEZY
@psychedelicstoday.bsky.social
Can art create a psychedelic experience without drugs? Mareesa Stertz discusses Sphinx Gate, the Hero’s Journey, integration, community, and plans to bring smaller sphinx installations around the country. bit.ly/4fLHGXc
12 veterans with severe treatment-resistant PTSD. Two psilocybin doses. 9 in remission at one month (75%). Symptoms dropped after prep therapy alone, before dosing. This change predicted outcomes. Expectancy didn't appear to impact performance. New from OSU! psychedelicstoday.com/2026/07/30/p...
Psilocybin Trial in Veterans With Treatment-Resistant PTSD Reports 75% Remission at One Month
An Ohio State pilot trial of psilocybin for veterans with PTSD reported remission in nine of twelve participants at one month.
psychedelicstoday.com
Tonight 🍄 Journeys + live Q&A with the filmmakers. The psilocybin therapy doc that talks to both sides — patients, veterans, facilitators, clinicians. Watch on Vimeo first, then join us + Psychetheatrics on Zoom, 5p PT / 6p MT. Free RSVP → www.eventbrite.com/e/journeys-a...
JOURNEYS: A Film Experience & Live Conversation with the Filmmakers
Watch JOURNEYS your way—on Vimeo or in community—then join Psychedelics Today for a live Q&A discussion with the creative team.
eventbrite.com
Same defense bill, same week: the House extended Pentagon psychedelic research through 2033 and blocked a Right to Try expansion for patients with life-threatening conditions. Fund the study, block the access. psychedelicstoday.com/2026/07/30/p...
Psychedelic Policy Briefing: Week of July 27th, 2026
Psychedelic policy this week: the House extends military research to 2033, blocks Right to Try, and the FDA may revisit MDMA.
psychedelicstoday.com
Can the mind become conscious of its own programming? Drs. Rachel Turetzky and Douglas Wingate explore the Eight-Circuit Model, developmental imprints, altered states, and psychedelic integration with Joe Moore and Kyle Buller. psychedelicstoday.com/2026/07/23/e...
Eli Lilly buys AtaiBeckley for up to $3.8B. Texas funds its own ibogaine trials. A manslaughter charge in Miami Beach. A Diné chapter asks the DEA to block commercial mescaline. All in one week. psychedelicstoday.com/2026/07/20/p...
Psychedelic Policy Briefing: Week of July 20th, 2026
Psychedelic policy this week: Texas ibogaine trials, Eli Lilly's $3.8B AtaiBeckley deal, a Miami retreat death charge, and Diné opposition to mescaline plans.
psychedelicstoday.com
Mitochondria, the body's strangest organelles, might be the link between biology, health, and mind — possibly responsible, even, for the materialization of consciousness into life. @quantamagazine.bsky.social www.quantamagazine.org/martin-picar...
Martin Picard’s Mitochondrial Theory of Mind | Quanta Magazine
The biologist’s bold “energetic view of life” looks to the body’s strangest organelles as the link between cells, health, and mind and the foundation of our experience of being alive.
quantamagazine.org
Your mind: a Thinker that decides what's true, and a Prover that finds evidence for it. Accuracy optional. Psychedelics suspend the Prover, briefly. Rachel Turetzky on metaprogramming and why insights fade: psychedelicstoday.com/2026/07/17/w...
The US wants ibogaine. Gabon just made iboga national strategic heritage: no research, export, or sale without state approval. A Gabonese official on what the rush looks like from the other side. psychedelicstoday.com/2026/07/13/i...
The Rush for Iboga Looks Different from Gabon
Gabon's new iboga decree puts sovereignty and reciprocity at the center of the ibogaine boom. A view from inside the Gabonese government.
psychedelicstoday.com
Congress filed the IBOGAINE Act: 60 days for the AG to decide whether ibogaine leaves Schedule I. Plus Oregon's psilocybin fee hikes and a former CIA officer telling a House panel the MKUltra research never stopped. psychedelicstoday.com/2026/07/05/p...
Psychedelic Policy Briefing: Week of July 6, 2026
The IBOGAINE Act, Oregon psilocybin fee hikes, DEA action on 7-OH, and MKUltra testimony in this week's psychedelic policy briefing.
psychedelicstoday.com
Clinical psychiatry was built to reduce pathology. It has no language for a client who says they just merged with everything. New op-ed makes the case for a different framework. psychedelicstoday.com/2026/07/03/8...
The Framework Gap in Psychedelic Practice: An Introduction to the 8-Circuit Model of Consciousness
The 8-Circuit Model of Consciousness offers psychedelic practitioners a map for the states clinical frameworks can't hold.
psychedelicstoday.com
In 1964, when LSD was still legal, the filmmaker Fellini did a supervised session he said shaped one of his films. It's a footnote in Italy's forgotten psychedelic history, ~900 patients treated between 1930 and 1967, then buried. New piece: psychedelicstoday.com/2026/06/29/i...
A Country That Recalls Its Own Forgetting
Italy's forgotten psychedelic history is resurfacing. Inside its research, policy, and the fight to keep these therapies public.
psychedelicstoday.com
A White House aide tied to Trump's psychedelics executive order is now reportedly on the FDA commissioner shortlist. The White House calls it "baseless hearsay." That plus Louisiana's Aug 1 research program in this week's briefing:
Three states moved on psychedelics this month. NC: $5.4M for research it can't act on. NH: ibogaine for the clinic, psilocybin killed for patients. IL: full legalization. New from Jack Gorsline: psychedelicstoday.com/2026/06/23/p...
Psychedelic Policy Briefing: Week of June 22nd, 2026
North Carolina, New Hampshire, and Illinois advance psychedelic policy bills on psilocybin, MDMA, and ibogaine research for veterans and trauma care.
psychedelicstoday.com
The US is fast-tracking MDMA for veterans and emergency-banning a ketamine analog it's seen 52 times in 8 years. Federal psychedelic policy in 2026 is conflicted. New briefing by Jack Gorsline maps contradiction: psychedelicstoday.com/2026/06/17/f...
Psychedelic Policy Briefing: Week of June 16, 2026
Federal psychedelic policy in 2026 divides over veterans access. Congress pushes MDMA and psilocybin research while the DEA bans analogs and stalls rescheduling. Inside the contradiction shaping psych...
psychedelicstoday.com
"They want me out of this world." His mother said it daily during a depression no one treated. Now he builds an AI tool for therapists and argues they belong beside practitioners, not in place of them. He also discusses AI risks in the therapy mix. psychedelicstoday.com/2026/06/12/o...
Out of This World: Why AI Belongs Beside the Therapist
Safar founder Sabba Nazhand. Why AI in mental health care should work beside therapists, not replace them, and the risks builders must face.
psychedelicstoday.com
108 psychedelic bills across 41 states this term. Colorado just made Indigenous benefit-sharing a condition of its ibogaine program, a first. Tennessee passed the HOPE Act. Michigan's fighting over opioid settlement money. Our new weekly state policy briefing: psychedelicstoday.com/2026/06/11/p...
Psychedelic Policy Briefing: June 11, 2026
State-by-state breakdown of 2026 psychedelic policy: ibogaine research, pilot programs, benefit sharing, and the political fights shaping legal access.
psychedelicstoday.com
Utah's HB 390 funds a clinical study of MDMA, psilocybin, and 5-MeO-DMT for veterans with treatment-resistant PTSD. Not legalization, not decriminalization. First state to name 5-MeO-DMT in law. psychedelicstoday.com/2026/06/09/u...
Utah’s Quiet Revolution: Why HB 390 May Be the Most Significant Psychedelic Legislation of 2026
Utah's HB 390 funds clinical research into MDMA, psilocybin, and 5-MeO-DMT for veterans with treatment-resistant PTSD. What the law does and does not do.
psychedelicstoday.com
ARPA-H committed $50M to psychedelic research. At the Federal Summit on Psychedelic Medicine in D.C., the conversation was about implementation: approval, reimbursement, veterans access. We were there and loved the meeting. psychedelicstoday.com/2026/05/22/a...
At the Federal Psychedelic Medicine Summit, the Mood Was Urgent, Practical, and Increasingly Coordinated
Federal leaders, veterans advocates, and investors gathered in D.C. to work through what it will actually take to implement psychedelic medicine at scale.
psychedelicstoday.com
A psychedelic therapy playlist is not background music. Lyrics, tempo, key, track length, silence, and transitions all change the room. The new piece on Psychedelics Today looks at what practitioners need to understand before pressing play. psychedelicstoday.com/2026/05/13/m...
Music in Psychedelic-Assisted Therapy: An Introduction to Sound, Playlist Curation, and Why Every Practitioner Needs to Understand Both
Learn how music shapes psychedelic-assisted therapy, from playlist design and emotional arc to ketamine, psilocybin, and emerging research.
psychedelicstoday.com
Private religious practices are linked to lower blood pressure spikes during stress
Private religious practices are linked to lower blood pressure spikes during stress
People who frequently pray or read religious texts in private tend to experience lower blood pressure spikes when stressed. A new study provides evidence that specific religious behaviors, rather than general spirituality, help regulate the body's stress response.
psypost.org
Psychedelic conference in Berlin? Sounds perfect. Starts May 15! Take part of Europe’s biggest event for mental health, psychedelic science, wellness, longevity and human flourishing. bit.ly/3R1a6Uz
TRYP EXPO Berlin 2026 – Science – Psychedelics – Music – Wellness
Europes biggest event for mental health, psychedelic science, wellness, festival and human flourishing. ADVANCE YOUR MIND – EXPAND YOUR WORLD May 15–17, 2026 · Funkhaus Berlin
bit.ly
Andrew Feldmár argues that psychedelic psychotherapy begins with relationship, not protocol, certainty, or promises of cure. Content note: brief mention of suicide. psychedelicstoday.com/2026/05/08/n...
No Promises and No Goals
Andrew Feldmár argues that psychedelic psychotherapy begins with relationship, not protocol, certainty, or promises of cure.
psychedelicstoday.com
Erica Rex joins Psychedelics Today to discuss trauma, integration, psychedelic hype, and her book Seeing What Is There. A sharp conversation on what psychedelics can open up, and what still has to happen after the session ends. psychedelicstoday.com/2026/04/23/e...
Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy
Erica Rex discusses Seeing What Is There, trauma, integration, psychedelic hype, and the limits of psychiatric medicine.
psychedelicstoday.com
Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways psychedelicstoday.com/2026/04/20/w...
Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways
Trump’s April 2026 executive order speeds psychedelic drug review and research, but stops short of legalization, approval, or insurance coverage.
psychedelicstoday.com
open.substack.com/pub/jomo137/... This paper should be a bigger deal than it probably will be. A new U.S. multi-criteria decision analysis found that federal drug policy does not line up with expert rankings of actual harm. Fentanyl, meth, crack, and heroin ranked highest.
Towards a Science Based Drug Policy? Or Nah?
This paper should be a bigger deal than it probably will be.
open.substack.com
Join the Chacruna Institute team in San Francisco coming up soon!! This conference is really great. Academic, culturual and connecting. If you can make it, go to the bay for this one. www.psychedelic-culture.net
PSYCHEDELIC CULTURE
psychedelic-culture.net
Betty Aldworth and Ismail Ali, co-executive directors of MAPS, join Psychedelics Today to discuss leadership transition, the future of MAPS, and where psychedelic research, education, and policy may be headed next. psychedelicstoday.com/2026/03/19/b...
Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics
MAPS co-executive directors Betty Aldworth and Ismail Ali discuss leadership, research, policy, and the future of MAPS.
psychedelicstoday.com